Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

R&D Expenses

$261.10M

TTM · Period ending: Jun 30, 2026 · USD

BIO R&D Expenses

Latest reported$261.10Mperiod endingJun 30, 2026

BIO TTM R&D Expenses ($0.00 → $261.10M)

TTM R&D Expenses

High-resolution chart · PNG

BIO r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	261,100,000
Mar 31, 2026	260,400,000
Dec 31, 2025	271,000,000
Sep 30, 2025	284,924,000
Jun 30, 2025	304,621,000
Mar 31, 2025	303,425,000
Dec 31, 2024	293,900,000
Sep 30, 2024	276,489,000
Jun 30, 2024	229,027,000
Mar 31, 2024	234,765,000
Dec 31, 2023	245,741,000
Sep 30, 2023	249,728,000
Jun 30, 2023	276,142,000
Mar 31, 2023	278,134,000
Dec 31, 2022	262,718,000
Sep 30, 2022	266,391,000
Jun 30, 2022	260,923,000
Mar 31, 2022	257,280,000
Dec 31, 2021	271,657,000
Sep 30, 2021	267,549,000
Jun 30, 2021	262,614,000
Mar 31, 2021	251,207,000
Dec 31, 2020	226,598,000
Sep 30, 2020	217,902,000
Jun 30, 2020	206,300,000
Mar 31, 2020	204,438,000
Dec 31, 2019	202,710,000
Sep 30, 2019	198,715,000
Jun 30, 2019	200,016,000
Mar 31, 2019	197,344,000
Dec 31, 2018	199,196,000
Sep 30, 2018	222,940,000
Jun 30, 2018	235,067,000
Mar 31, 2018	250,240,000
Dec 31, 2017	250,301,000
Sep 30, 2017	231,026,000
Jun 30, 2017	219,578,000
Mar 31, 2017	209,126,000
Dec 31, 2016	208,224,000
Sep 30, 2016	206,568,000
Jun 30, 2016	199,980,000
Mar 31, 2016	194,356,000
Dec 31, 2015	192,972,000
Sep 30, 2015	196,372,000
Jun 30, 2015	205,822,000
Mar 31, 2015	214,992,000
Dec 31, 2014	220,333,000
Sep 30, 2014	216,894,000
Jun 30, 2014	217,028,000
Mar 31, 2014	214,535,000
Dec 31, 2013	213,933,000
Sep 30, 2013	217,862,000
Jun 30, 2013	213,946,000
Mar 31, 2013	213,058,000
Dec 31, 2012	214,040,000
Sep 30, 2012	204,375,000
Jun 30, 2012	200,758,000
Mar 31, 2012	196,632,000
Dec 31, 2011	186,439,000
Sep 30, 2011	181,594,000
Jun 30, 2011	179,081,000
Mar 31, 2011	174,733,000
Dec 31, 2010	172,266,000
Sep 30, 2010	171,509,000
Jun 30, 2010	168,151,000
Mar 31, 2010	166,696,000
Dec 31, 2009	163,585,000
Sep 30, 2009	160,195,000
Jun 30, 2009	159,509,000
Mar 31, 2009	159,181,000
Dec 31, 2008	159,518,000
Sep 30, 2008	158,253,000
Jun 30, 2008	152,568,000
Mar 31, 2008	145,243,000
Dec 31, 2007	140,535,000
Sep 30, 2007	134,006,000
Jun 30, 2007	131,849,000
Mar 31, 2007	128,066,000
Dec 31, 2006	123,376,000
Sep 30, 2006	121,159,000
Jun 30, 2006	118,844,000
Mar 31, 2006	116,372,000
Dec 31, 2005	115,104,000
Sep 30, 2005	115,880,000
Jun 30, 2005	113,788,000
Mar 31, 2005	110,834,000
Dec 31, 2004	110,135,000
Sep 30, 2004	104,627,000
Jun 30, 2004	101,820,000
Mar 31, 2004	99,006,000
Dec 31, 2003	94,270,000
Sep 30, 2003	90,793,000
Jun 30, 2003	87,007,000
Mar 31, 2003	84,082,000
Dec 31, 2002	82,935,000
Sep 30, 2002	82,024,000
Jun 30, 2002	80,461,000
Mar 31, 2002	78,356,000
Dec 31, 2001	76,543,000
Sep 30, 2001	71,071,000